![]() ![]() | Jacques, S., Arjomand, A., Perée, H., COLLINS, P., Mayer, A., Lavergne, A., Wéry, M., Mni, M., Hego, A., Thuillier, V., Becker, G., Bahri, M. A., Plenevaux, A., Di Valentin, E., Oury, C., MOUTSCHEN, M., Delvenne, P., Paquot, N., & Rahmouni, S. (2021). Dual‑specificity phosphatase 3 deletion promotes obesity, non‑alcoholic steatohepatitis and hepatocellular carcinoma. Scientific Reports, 11, 5817. doi:10.1038/s41598-021-85089-6 ![]() |
![]() ![]() | Jacques, S., Vandereyken, M., Arjomand, A., Rahmouni, S., & Oury, C. (21 January 2019). DUSP3 genetic depletion predispose to obesity-induced hepatocellular carcinoma [Poster presentation]. Integrated pathways of disease in NASH and NAFLD, Santa Fe, United States. |
Jacques, S., Arjomand, A., Vandereyken, M., Oury, C., & Rahmouni, S. (24 July 2017). Dual-specificity-phosphatase 3 (DUSP3) deletion promotes liver inflammation and high fat diet-induced hepatocellular carcinoma [Poster presentation]. Sophie Jacques, Paris, France. |
Jacques, S., Arjomand, A., Vandereyken, M., Moutschen, M., Oury, C., & Rahmouni, S. (08 December 2016). DUSP3 genetic deletion predispose to obesity-induced hepatocellular carcinoma [Poster presentation]. Séminaire des chercheurs Télévie, Louvain, Belgium. |